AMGEN INC is 56.1x more valuable than Denali Therapeutics Inc. by market capitalization ($183.41 B vs $3.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DNLI | AMGN |
|---|---|---|
| Market cap | $3.27 B | $183.41 B |
| US-listed rank | #1734 | #79 |
| Revenue (latest FY) | $0.00 | $36.75B |
| Net income (latest FY) | -$512.54M | $7.71B |
| Net margin | - | 21.0% |
| P/E (trailing FY) | - | 23.8 |
| SEC filings | 763 | 1,011 |
AMGEN INC is 56.1x more valuable than Denali Therapeutics Inc. by market capitalization ($183.41 B vs $3.27 B).
In their latest fiscal years, Denali Therapeutics Inc. reported $0.00 in revenue while AMGEN INC reported $36.75B.
Full pages: Denali Therapeutics Inc. and AMGEN INC, or browse the full rankings.